Cresset Asset Management, LLC Repligen Corp Transaction History
Cresset Asset Management, LLC
- $23.6 Billion
- Q2 2024
A detailed history of Cresset Asset Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Cresset Asset Management, LLC holds 1,940 shares of RGEN stock, worth $269,815. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,940
Previous 2,061
5.87%
Holding current value
$269,815
Previous $379,000
35.62%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RGEN
# of Institutions
496Shares Held
53.9MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.05 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$705 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$641 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$242 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$198 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.72B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....